Heparanase: another renal player controlled by vitamin D

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Vitamin D deficiency is common in chronic kidney disease (CKD).
• Vitamin D has known nephroprotective effects, partly via the renin-angiotensin-aldosterone system.
• Other signaling pathways modulated by vitamin D are also implicated in kidney health.

Purpose of the Study:

• To identify novel molecular targets of vitamin D's antiproteinuric activity.
• To investigate the role of heparanase in vitamin D's kidney-protective mechanisms.

Main Methods:

• Analysis of recent work published in the Journal of Pathology.
• Identification of heparanase as a target of vitamin D.

Main Results:

• Heparanase, an enzyme degrading heparan sulfate, was identified as a novel target of vitamin D.
• Vitamin D was shown to inhibit heparanase expression.
• This inhibition is linked to vitamin D's antiproteinuric activity.

Conclusions:

• Vitamin D inhibits heparanase, offering a new understanding of its kidney-protecting effects.
• Targeting heparanase with vitamin D may be a therapeutic strategy for proteinuric and non-proteinuric chronic kidney diseases.